CDT Equity Inc. (CDT)
NASDAQ: CDT · Real-Time Price · USD
0.7420
-0.0330 (-4.26%)
At close: Jun 9, 2026, 4:00 PM EDT
0.7394
-0.0026 (-0.35%)
Pre-market: Jun 10, 2026, 8:42 AM EDT
CDT Equity Employees
CDT Equity had 4 employees as of December 31, 2025. The number of employees decreased by 2 or -33.33% compared to the previous year.
Employees
4
Change (1Y)
-2
Growth (1Y)
-33.33%
Revenue / Employee
n/a
Profits / Employee
-$9,806,000
Market Cap
3.60M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 4 | -2 | -33.33% |
| Dec 31, 2024 | 6 | -1 | -14.29% |
| Dec 31, 2023 | 7 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| GeoVax Labs | 19 |
| Virax Biolabs Group | 19 |
| VivoSim Labs | 14 |
| Soligenix | 14 |
| Azitra | 13 |
| Decoy Therapeutics | 11 |
| Revelation Biosciences | 9 |
| Alzamend Neuro | 6 |
CDT News
- 12 days ago - CDT Equity receives Nasdaq notice for delayed quarterly report - TheFly
- 12 days ago - CDT Equity Inc. Announces Receipt of Nasdaq Deficiency Letter - GlobeNewsWire
- 13 days ago - CDT Equity granted Canadian patent for AZD5904 in male infertility - TheFly
- 14 days ago - CDT Announces Canadian Patent for AZD5904 in Male Infertility - GlobeNewsWire
- 4 weeks ago - CDT Notes Sarborg Filing of Substance of Matter Patent in Cystic Fibrosis Market - GlobeNewsWire
- 4 weeks ago - CDT Equity announces AZD5904 progresses into patent cooperation treaty phase - TheFly
- 5 weeks ago - CDT Advances AZD5904 into Global Patent Phase and Initiates Partnering Discussions - GlobeNewsWire
- 6 weeks ago - CDT Equity management to meet with Maxim - TheFly